5,6-dimethoxy-2-(4-piperidinylmethyl)-1-indanonehydrochloride CAS:120013-39-0

5,6-dimethoxy-2-(4-piperidinylmethyl)-1-indanonehydrochloride has shown promise in preclinical studies as a potential therapeutic agent for various medical conditions. Its primary applications include its use as a research tool in neuroscience for studying neurotransmitter pathways and receptor interactions. This compound's unique structure allows it to modulate specific receptors in the brain, making it valuable for investigating neurobiological processes. Furthermore, 5,6-dimethoxy-2-(4-piperidinylmethyl)-1-indanonehydrochloride exhibits anti-inflammatory properties, suggesting its potential use in treating inflammatory disorders such as rheumatoid arthritis and inflammatory bowel disease. Its ability to inhibit certain enzymes involved in inflammation makes it a promising candidate for drug development in this field. In addition, preliminary studies have indicated that this compound may have neuroprotective effects, potentially benefiting individuals with neurodegenerative diseases like Alzheimer's and Parkinson's. By targeting key molecular pathways involved in neuronal damage, this compound could offer new possibilities for the treatment and management of these debilitating conditions. Overall, the versatile pharmacological properties of 5,6-dimethoxy-2-(4-piperidinylmethyl)-1-indanonehydrochloride make it a valuable compound for both basic research and potential therapeutic interventions in various medical fields, ranging from neuroscience to inflammation and neurodegeneration.